ZEPBOUND

Class [005]
Pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of alopecia; pharmaceutical preparations for the treatment of dermatological diseases and disorders, namely atopic dermatitis, Psoriasis; pharmaceutical preparations for the treatment of autoimmune diseases and disorders, namely lupus; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely bone diseases, fibromyalgia; pharmaceutical preparations for the treatment of cardiovascular diseases, cancer, vascular diseases, metabolic diseases and disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, hypoglycemia, gout, muscular dystrophy, anemia, metabolic syndrome, and osteoarthritis; pharmaceutical preparations for the treatment and prevention of migraines, headaches, cluster headaches and pain; pharmaceutical preparations for the treatment of coronavirus; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Parkinson's disease, and multiple sclerosis; pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's disease, Huntington's disease and cerebral palsy, brain injury, spinal cord injury and seizure disorders; pharmaceutical preparations for the treatment of mental disorders, namely pharmaceutical preparations for the treatment of dementia and for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, ulcerative colitis, inflammatory tissue diseases; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, Crohn's disease; pharmaceutical preparations for the treatment of metabolic disorders, namely diabetes, obesity, dyslipidemia; pharmaceutical preparations for the treatment of arthritis, psoriatic arthritis, rheumatoid arthritis; pharmaceutical preparations for the treatment of cardiovascular diseases, namely heart failure; pharmaceutical preparations for the treatment of diseases and disorders of the endocrine system, namely menopause, diabetes, Addison's disease, Cushing's disease, Graves' disease, hyperthyroidism, hypothyroidism